The enhancement of recombinant antibody production in Chinese Hamster Ovary (CHO) cells is a crucial aspect of biopharmaceutical development. To maximize efficacy, various strategies are employed, including genetic engineering of the host cells and optimization of growth conditions. Moreover, util